Cited by 407Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychotherapy Techniques and Applications

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis

Open access

Taylor, Matthew J., Freemantle, Nick, Geddes, John R., Bhagwagar, Zubin·2006·Archives of General Psychiatry

DOI 10.1001/archpsyc.63.11.1217PMC PMC2211759

Open this paper in CoChat — free account

Abstract

CONTEXT: Selective serotonin reuptake inhibitors (SSRIs) are often described as having a delayed onset of effect in the treatment of depression. However, some trials have reported clinical improvement as early as the first week of treatment. OBJECTIVE: To test the alternative hypotheses of delayed vs early onset of antidepressant action with SSRIs in patients with unipolar depression. DATA SOURCES: Trials identified by searching CENTRAL, The Cochrane Collaboration database of controlled trials (2005), and the reference lists of identified trials and other systematic reviews. STUDY SELECTION: Randomized controlled trials of SSRIs vs placebo for the treatment of unipolar depression in adults that reported outcomes for at least 2 time points in the first 4 weeks of treatment (50 trials from >500 citations identified). Trials were excluded if limited to participants older than 65 years or specific comorbidities. DATA EXTRACTION: Data were extracted on trial design, participant characteristics, and outcomes by a single reviewer. DATA SYNTHESIS: Pooled estimates of treatment effect on depressive symptom rating scales were calculated for weeks 1 through 6 of treatment. In the primary analysis, the pattern of response seen was tested against alternative models of onset of response. The primary analysis incorporated data from 28 randomized controlled trials (n=5872). A model of early treatment response best fit the experimental data. Treatment with SSRIs rather than placebo was associated with clinical improvement by the end of the first week of use. A secondary analysis indicated an increased chance of achieving a 50% reduction in Hamilton Depression Rating Scale scores by 1 week (relative risk, 1.64; 95% confidence interval, 1.2-2.25) with SSRI treatment compared with placebo. CONCLUSIONS: Treatment with SSRIs is associated with symptomatic improvement in depression by the end of the first week of use, and the improvement continues at a decreasing rate for at least 6 weeks.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.63.11.1217

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
A molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Systematic Reviews: Rationale for systematic reviews
Mulrow, C. D. (1994) · BMJ · doi:10.1136/bmj.309.6954.597 · Cited by 1,677
Current advances and trends in the treatment of depression
Blier, P., & de Montigny, C. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90315-8 · Cited by 1,113
Development of β-adrenergic receptor subsensitivity by antidepressants
Banerjee, S. P., Kung, L. S., Riggi, S. J., & Chanda, S. K. (1977) · Nature · doi:10.1038/268455a0 · Cited by 722
Depression: a case of neuronal life and death?
Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 630
THE TREATMENT OF DEPRESSIVE STATES WITH G 22355 (IMIPRAMINE HYDROCHLORIDE)
Kuhn, R. (1958) · American Journal of Psychiatry · doi:10.1176/ajp.115.5.459 · Cited by 615
Increased Positive Versus Negative Affective Perception and Memory in Healthy Volunteers Following Selective Serotonin and Norepinephrine Reuptake Inhibition
Harmer, C. J., Shelley, N. C., Cowen, P. J., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.7.1256 · Cited by 554

Show all 62 references

Research works printed but not linked: 1

[24]Alderson P Green S Higgins JPT Cochrane Reviewers' Handbook 4.2.2 2004 Chichester, England John Wiley & Sons Ltd

Sorted by citations

Major depressive disorder
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Self-citation
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 909
Major depressive disorder
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 910
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Self-citation
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults
Kennedy, S. H., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 529
Effect of Acute Antidepressant Administration on Negative Affective Bias in Depressed Patients
Harmer, C. J., O’Sullivan, U., Favaron, E., Massey-Chase, R., Ayres, R., Reinecke, A., Goodwin, G. M., & Cowen, P. J. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09020149 · Cited by 485
Neurocognitive Mechanisms in Depression: Implications for Treatment
Clark, L., Chamberlain, S. R., & Sahakian, B. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.31.060407.125618 · Cited by 446
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms
Uher, R., Perlis, R. H., Henigsberg, N., Zobel, A., Rietschel, M., Mors, O., Hauser, J., Dernovsek, M. Z., Souery, D., Bajs, M., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711001905 · Cited by 420
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
Abnormal temporal difference reward-learning signals in major depression
Kumar, P., Waiter, G., Ahearn, T., Milders, M., Reid, I., & Steele, J. D. (2008) · Brain · doi:10.1093/brain/awn136 · Cited by 374
Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment
McCabe, C., Mishor, Z., Cowen, P. J., & Harmer, C. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.11.001 · Cited by 365
Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects
Kelly, J. R., Allen, A. P., Temko, A., Hutch, W., Kennedy, P. J., Farid, N., Murphy, E., Boylan, G., Bienenstock, J., Cryan, J. F., et al. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.11.018 · Cited by 355
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R. C., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 314
Behavioral Effects of Chronic Fluoxetine in BALB/cJ Mice Do Not Require Adult Hippocampal Neurogenesis or the Serotonin 1A Receptor
Holick, K. A., Lee, D. C., Hen, R., & Dulawa, S. C. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301399 · Cited by 326
Inflammation, Glutamate, and Glia in Depression:A Literature Review
McNally, L., Bhagwagar, Z., & Hannestad, J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016734 · Cited by 289
Self-citation
Effect of a single dose of citalopram on amygdala response to emotional faces
Murphy, S. E., Norbury, R., O'Sullivan, U., Cowen, P. J., & Harmer, C. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.056093 · Cited by 255
The timing of antidepressant effects: a comparison of diverse pharmacological and somatic treatments
Machado-Vieira, R., Baumann, J., Wheeler-Castillo, C., Latov, D., Henter, I. D., Salvadore, G., & Zarate, C. A. (2010) · Pharmaceuticals · doi:10.3390/ph3010019 · Cited by 263
Fluvoxamine versus other anti-depressive agents for depression
Omori, I. M., Watanabe, N., Nakagawa, A., Cipriani, A., Barbui, C., McGuire, H., Churchill, R. C., & Furukawa, T. A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006114.pub2 · Cited by 213
The drugs don’t work? antidepressants and the current and future pharmacological management of depression
Penn, E., & Tracy, D. K. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312445469 · Cited by 222
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder
Jakubovski, E., Varigonda, A. L., Freemantle, N., Taylor, M. J., & Bloch, M. H. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030331 · Cited by 200
Self-citation
Rapid Onset of Antidepressant Action: A New Paradigm in the Research and Treatment of Major Depressive Disorder
Machado-Vieira, R., Salvadore, G., Luckenbaugh, D. A., Manji, H. K., & Zarate, C. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0610 · Cited by 195
Antidepressant medications reduce subcortical-cortical resting-state functional connectivity in healthy volunteers
McCabe, C., & Mishor, Z. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.05.051 · Cited by 184
‘It's the way that you look at it’—a cognitive neuropsychological account of SSRI action in depression
Harmer, C. J., & Cowen, P. J. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0407 · Cited by 197
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
Zheng, W., Zhou, Y.-L., Liu, W.-J., Wang, C.-Y., Zhan, Y.-N., Li, H.-Q., Chen, L.-J., Li, M. D., & Ning, Y.-P. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.09.013 · Cited by 180
A critical review of human endotoxin administration as an experimental paradigm of depression.
DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175
A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: Do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?
Walker, F. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.002 · Cited by 175
Machine learning approaches for integrating clinical and imaging features in late‐life depression classification and response prediction
Patel, M. J., Andreescu, C., Price, J. C., Edelman, K. L., Reynolds, C. F., & Aizenstein, H. J. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4262 · Cited by 174
Duloxetine versus other anti-depressive agents for depression
Cipriani, A., Koesters, M., Furukawa, T. A., Nosè, M., Purgato, M., Omori, I. M., Trespidi, C., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006533.pub2 · Cited by 172
Resting state functional connectivity and treatment response in late-life depression
Andreescu, C., Tudorascu, D. L., Butters, M. A., Tamburo, E., Patel, M., Price, J., Karp, J. F., Reynolds, C. F., & Aizenstein, H. (2013) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2013.08.007 · Cited by 153
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Hu, Y.-D., Xiang, Y.-T., Fang, J.-X., Zu, S., Sha, S., Shi, H., Ungvari, G. S., Correll, C. U., Chiu, H. F. K., Xue, Y., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291715002159 · Cited by 146
Smoking Induces Long-Lasting Effects through a Monoamine-Oxidase Epigenetic Regulation
Launay, J., Pino, M. D., Chironi, G. N., Callebert, J., Peoc’h, K., Mégnien, J. L., Mallet, J. J., Simon, A. C., & Rendu, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007959 · Cited by 143
Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders
Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2019) · Depression and Anxiety · doi:10.1002/da.22854 · Cited by 131
Trajectories of change in depression severity during treatment with antidepressants
Uher, R., Muthén, B., Souery, D., Mors, O. N., Jaracz, J., Placentino, A., Petrovic, A., Zobel, A. W., Henigsberg, N., Rietschel, M., et al. (2009) · Psychological Medicine · doi:10.1017/s0033291709991528 · Cited by 128
Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.
Koo, J. W., & Duman, R. S. (2009) · PubMed · Cited by 128
Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment
Godlewska, B. R., & Harmer, C. J. (2021) · Psychopharmacology · doi:10.1007/s00213-019-05448-0 · Cited by 123
Pathological Laughing and Crying
Wortzel, H. S., Oster, T. J., Anderson, C. A., & Arciniegas, D. B. (2008) · CNS Drugs · doi:10.2165/00023210-200822070-00001 · Cited by 124
Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials
Barbui, C., Furukawa, T. A., & Cipriani, A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.070693 · Cited by 120
Antidepressant Response and the Serotonin Transporter Gene-Linked Polymorphic Region
Taylor, M. J., Sen, S., & Bhagwagar, Z. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.034 · Cited by 121
Self-citation
Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
Tadić, A., Helmreich, I., Mergl, R., Hautzinger, M., Kohnen, R., Henkel, V., & Hegerl, U. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.04.014 · Cited by 113
Trajectories of Depression Severity in Clinical Trials of Duloxetine
Gueorguieva, R. V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.132 · Cited by 121
Short-term antidepressant treatment modulates amygdala response to happy faces
Norbury, R., Taylor, M. J., Selvaraj, S., Murphy, S. E., Harmer, C. J., & Cowen, P. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1597-1 · Cited by 109
Self-citation
The effects of serotonin manipulations on emotional information processing and mood
Merens, W., van der Does, W. A. J., & Spinhoven, P. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.032 · Cited by 113
Dentate gyrus neurogenesis and depression
Sahay, A., Drew, M. R., & Hen, R. (2007) · Progress in brain research · doi:10.1016/s0079-6123(07)63038-6 · Cited by 104
A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors
Hieronymus, F., Nilsson, S., & Eriksson, E. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.104 · Cited by 100
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B. M., Brand, U., Fleischhacker, W., Goodwin, G. M., Grunze, H., Knapp, M. R. J., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 103
Medical cannabis treatment for chronic pain: Outcomes and prediction of response
Aviram, J., Pud, D., Gershoni, T., Schiff‐Keren, B., Ogintz, M., Vulfsons, S., Yashar, T., Adahan, H., Brill, S., Amital, H., et al. (2020) · European Journal of Pain · doi:10.1002/ejp.1675 · Cited by 100
Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data
Taliaz, D., Spinrad, A., Barzilay, R., Barnett-Itzhaki, Z., Averbuch, D., Teltsh, O., Schurr, R., Darki-Morag, S., & Lerer, B. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01488-3 · Cited by 93
Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder
Varigonda, A. L., Jakubovski, E., & Bloch, M. H. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.07.768 · Cited by 93
A new paradigm for the prediction of antidepressant treatment response
Leuchter, A. F., Cook, I. A., Hunter, A. M., & Korb, A. S. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.4/afleuchter · Cited by 91
Prognostic Subgroups for Citalopram Response in the STAR*D Trial
Jakubovski, E., & Bloch, M. H. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08727 · Cited by 85
Onset, time course and trajectories of improvement with antidepressants
Lam, R. W. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.07.005 · Cited by 86
Plasma serotonin levels are associated with antidepressant response to SSRIs
Holck, A., Wolkowitz, O. M., Mellon, S. H., Reus, V. I., Nelson, J. C., Westrin, Å., & Lindqvist, D. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.063 · Cited by 82
An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress
Lu, J., Tjia, M., Mullen, B., Cao, B., Lukasiewicz, K., Shah-Morales, S., Weiser, S., Cameron, L. P., Olson, D. E., Chen, L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01159-1 · Cited by 84
A mechanistic account of serotonin’s impact on mood
Michely, J., Eldar, E., Martin, I. M., & Dolan, R. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16090-2 · Cited by 72
Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
Tran, P., Skolnick, P., Czobor, P., Huang, N. Y., Bradshaw, M., McKinney, A., & Fava, M. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.003 · Cited by 81
Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers
Simmons, A. N., Arce, E., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990149 · Cited by 82
Investigating the psychopharmacology of cognitive affective bias in rats using an affective tone discrimination task
Anderson, M. H., Munafo, M. R., & Robinson, E. S. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2932-5 · Cited by 79
The History and Current State of Antidepressant Clinical Trial Design
Gelenberg, A. J., Thase, M. E., Meyer, R. E., Goodwin, F. K., Katz, M. M., KRAEMER, H. C., Potter, W. Z., Shelton, R. C., D, M. F. M., Khan, A., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1001 · Cited by 78
Monoamine oxidases in development
Wang, C. C., Billett, E. E., Borchert, A., Kühn, H., & Ufer, C. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1065-7 · Cited by 82
Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis
Wagner, S., Engel, A., Engelmann, J., Herzog, D., Dreimüller, N., Müller, M. B., Tadić, A., & Lieb, K. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.07.003 · Cited by 73
Connecting Dots between Mitochondrial Dysfunction and Depression
Khan, M., Baussan, Y., & Hébert-Chatelain, É. (2023) · Biomolecules · doi:10.3390/biom13040695 · Cited by 77
Metareview on Short-Term Effectiveness and Safety of Antidepressants for Depression: An Evidence-Based Approach to Inform Clinical Practice
Cipriani, A., Geddes, J. R., Furukawa, T. A., & Barbui, C. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200903 · Cited by 72
Self-citation
Accelerating response to antidepressant treatment in depression: A review and clinical suggestions
Nakajima, S., Suzuki, T., Watanabe, K., Kashima, H., & Uchida, H. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.001 · Cited by 74
Pharmacological approaches to the treatment of complicated grief: rationale and a brief review of the literature
Bui, E., Nadal-Vicens, M., & M. Simon, N. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.2/ebui · Cited by 71
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels
Barbon, A., Caracciolo, L., Orlandi, C., Musazzi, L., Mallei, A., Via, L. L., Bonini, D., Mora, C., Tardito, D., Gennarelli, M., et al. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.07.013 · Cited by 70
Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
James, G. M., Baldinger, P., Philippe, C., Kranz, G. S., Vanicek, T., Hahn, A., Gryglewski, G., Hienert, M., Spies, M., Traub‐Weidinger, T., et al. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00048 · Cited by 72
Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial - SELECT TDCS: Design, rationale and objectives
Brunoni, A. R., Valiengo, L. D. C. L., Baccaro, A., Zanao, T. A., de Oliveira, J. F., Vieira, G. P., Bueno, V. F., Goulart, A. C., Boggio, P. S., Lotufo, P. A., et al. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.09.007 · Cited by 71
Initiation of Behavioral Response to Antidepressants by Cholecystokinin Neurons of the Dentate Gyrus
Medrihan, L., Sagi, Y., Inde, Z., Krupa, O., Daniels, C., Peyrache, A., & Greengard, P. (2017) · Neuron · doi:10.1016/j.neuron.2017.06.044 · Cited by 67
Anxiety during ketamine infusions is associated with negative treatment responses in major depressive disorder
Aust, S., Gärtner, M., Basso, L., Otte, C., Wingenfeld, K., Chae, W. R., Heuser, I., Regen, F., Cosma, N. C., van Hall, F., et al. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.02.005 · Cited by 73
Future Suicide Attempt and Responses to Serotonergic Challenge
Keilp, J. G., Oquendo, M. A., Stanley, B., Burke, A. K., Cooper, T. B., Malone, K. M., & Mann, J. J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.28 · Cited by 67
A neurocognitive model for understanding treatment action in depression
Warren, M., Pringle, A., & Harmer, C. J. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0213 · Cited by 75
A unified model of ketamine’s dissociative and psychedelic properties
Marguilho, M., Figueiredo, I., & Castro-Rodrigues, P. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221140011 · Cited by 71
The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study
Norbury, R., Mackay, C. E., Cowen, P. J., Goodwin, G. M., & Harmer, C. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002091 · Cited by 65
Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression
Dreimüller, N., Schlicht, K. F., Wagner, S., Peetz, D., Borysenko, L., Hiemke, C., Lieb, K., & Tadić, A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.017 · Cited by 64
Vilazodone, a novel dual-acting serotonergic antidepressant for managing major depression
Khan, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903286396 · Cited by 64
Depression in primary care: part 2—management
Ramanuj, P., Ferenchick, E. K., & Pincus, H. A. (2019) · BMJ · doi:10.1136/bmj.l835 · Cited by 68
Efficacy and Safety of Vilazodone in Major Depressive Disorder
Croft, H. A., Pomara, N., Gommoll, C., Chen, D., Núñez, R., & Mathews, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m08992 · Cited by 64
How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database
Baldwin, D. S., Stein, D. J., Dolberg, O. T., & Bandelow, B. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1019 · Cited by 63
Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression
Kemp, D. E., Ganocy, S. J., Brecher, M., Carlson, B. X., Edwards, S., Eudicone, J. M., Evoniuk, G. E., Jansen, W. T., Leon, A. C., Minkwitz, M. C., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.10.026 · Cited by 62
Antidepressants and the adolescent brain
Cousins, L., & Goodyer, I. M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573542 · Cited by 61
Prenatal stress and models explaining risk for psychopathology revisited: Generic vulnerability and divergent pathways
Huizink, A. C., & de Rooij, S. R. (2018) · Development and Psychopathology · doi:10.1017/s0954579418000354 · Cited by 68
Folate Augmentation of Treatment – Evaluation for Depression (FolATED): randomised trial and economic evaluation
Bedson, E., Bell, D., Carr, D. F., Carter, B., Hughes, D. A., Jorgensen, A., Lewis, H., Lloyd, K. R., McCaddon, A., Moat, S. J., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18480 · Cited by 63
Limitations of current medical treatments for depression: Disturbed circadian rhythms as a possible therapeutic target
LADER, M. H. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.05.004 · Cited by 61
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial
Erritzøe, D., Barba, T., Greenway, K. T., Murphy, R., Martell, J., Giribaldi, B., Timmermann, C., Murphy-Beiner, A., Baker-Jones, M., Nutt, D., et al. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102799 · Cited by 68
Antidepressants and mood stabilizers effects on histone deacetylase expression in C57BL/6 mice: Brain region specific changes
Ookubo, M., Kanai, H., Aoki, H., & Yamada, N. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.028 · Cited by 60
The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences
Hegerl, U., & Mergl, R. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109106930 · Cited by 54
Beyond negative valence: 2-week administration of a serotonergic antidepressant enhances both reward and effort learning signals
Scholl, J., Kolling, N., Nelissen, N., Browning, M., Rushworth, M. F. S., & Harmer, C. J. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2000756 · Cited by 58
Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder
Varigonda, A. L., Jakubovski, E., Taylor, M. J., Freemantle, N., Coughlin, C. G., & Bloch, M. H. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.05.004 · Cited by 59
Self-citation
Rapid response predicts binge eating and weight loss in binge eating disorder: Findings from a controlled trial of orlistat with guided self-help cognitive behavioral therapy
Grilo, C. M., & Masheb, R. M. (2007) · Behaviour Research and Therapy · doi:10.1016/j.brat.2007.05.010 · Cited by 55
A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission
Tan, S. K. H., Hartung, H., Visser-Vandewalle, V. E. R. M., Steinbusch, H. W. M., Temel, Y., & Sharp, T. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.027 · Cited by 53
Antidepressant-related sexual dysfunction — Perspectives from neuroimaging
Graf, H., Walter, M., Metzger, C. D., & Abler, B. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.003 · Cited by 53
Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies.
Warden, S. J., & Haney, E. M. (2008) · PubMed · Cited by 53
Current and emerging drug treatments for binge eating disorder
Reas, D. L., & Grilo, C. M. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.879291 · Cited by 52
Resting-state brain alteration after a single dose of SSRI administration predicts 8-week remission of patients with major depressive disorder
Cheng, Y., Xu, J., Arnone, D., Nie, B., Yu, H., Jiang, H., Bai, Y., Luo, C., Campbell, R. A. A., Shan, B., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291716002440 · Cited by 51
Antidepressant drug action--From rapid changes on network function to network rewiring
Rantamäki, T., & Yalcin, I. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.06.001 · Cited by 50
Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial
Johansen, A., Armand, S., Plavén-Sigray, P., Nasser, A., Ozenne, B., Petersen, I. N., Keller, S. H., Madsen, J., Beliveau, V., Møller, K., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02285-8 · Cited by 53
Predicting antidepressant response by monitoring early improvement of individual symptoms of depression: individual patient data meta-analysis
de Vries, Y. A., Roest, A. M., Bos, E. H., Burgerhof, J. G. M., van Loo, H. M., & de Jonge, P. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.122 · Cited by 50

Authors: Taylor, M. J., Freemantle, N., Geddes, J. R., & Bhagwagar, Z.
Affiliations: Warneford Hospital (GB)
ORCID: Taylor, Matthew J.
Freemantle, Nick
Geddes, John R.
Bhagwagar, Zubin
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 2006-11-01
Volume: 63
Issue: 11
Pages: 1217
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.63.11.1217
PMC: PMC2211759
OpenAlex: W2140505555
Cited by: 406
References: 62
Citations by year: 2026: 20 · 2025: 31 · 2024: 17 · 2023: 25 · 2022: 18 · 2021: 14 · 2020: 14 · 2019: 16 · 2018: 12 · 2017: 12 · 2016: 15 · 2015: 21 · 2014: 15 · 2013: 23 · 2012: 29
FWCI: 14.84
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Research Portal (King's College London) (submittedVersion)
University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Funders: Wellcome Trust (075694)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
Keywords: selective serotonin reuptake inhibitors, antidepressant onset of action, major depressive disorder, early treatment response, placebo comparison, Hamilton Depression Rating Scale, antidepressant efficacy
MeSH terms: Adult, Age Factors, Depressive Disorder, Double-Blind Method, Humans, Middle Aged, Placebos, Psychiatric Status Rating Scales, Research Design, Risk, Time Factors, Confidence Intervals, Randomized Controlled Trials as Topic, Treatment Outcome, Selective Serotonin Reuptake Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant Action: Systematic Review and Meta-analysis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks